Back
Ultragenyx Pharmaceutical Stock Price Chart
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
42.61
Seasonality Move:
12.29%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.46 | Sell |
| 20-day SMA: | 42.72 | Sell |
| 50-day SMA: | 45.61 | Sell |
| 200-day SMA: | 42.06 | Sell |
| 8-day EMA: | 41.51 | Sell |
| 20-day EMA: | 42.79 | Sell |
| 50-day EMA: | 44.59 | Sell |
| 200-day EMA: | 44.26 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.38 | Sell |
| Relative Strength Index (14 RSI): | 36.17 | Sell |
| Chaikin Money Flow: | -526969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.16 - 45.34) | Sell |
| Bollinger Bands (100): | (43.31 - 49.39) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 41.12 while RARE 8-day simple moving average is 41.46, which is a Sell signal.
- The stock price of RARE is 41.12 while Ultragenyx Pharmaceutical 20-day SMA is 42.72, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 45.61 while RARE share price is 41.12, making it a Sell technically.
- RARE stock price is 41.12 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.06, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.42B
Price in USD:
41.12
Share Volume:
673.6K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
54.98
52-Week Low:
31.52
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 41.12 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 41.12 while RARE 8-day exponential moving average is 41.51, which is a Sell signal.
- The stock price of RARE is 41.12 while Ultragenyx Pharmaceutical 20-day EMA is 42.79, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 44.59 while RARE share price is 41.12, making it a Sell technically.
- RARE stock price is 41.12 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.26, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -1.38, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 36.17, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (41.16 - 45.34), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (43.31 - 49.39), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.